These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12497567)

  • 41. An evaluation of nerve repair with nerve allografts in normal and immunologically tolerant rats.
    Zalewski AA; Silvers WK
    J Neurosurg; 1980 Apr; 52(4):557-63. PubMed ID: 7373379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of histocompatibility as a factor in the repair of nerve with a frozen nerve allograft.
    Zalewski AA; Gulati AK
    J Neurosurg; 1982 Apr; 56(4):550-4. PubMed ID: 6977623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged allograft survival resulting from donor pretreatment with phytohemagglutinin-P.
    Ludwin D; Singal DP
    Transplantation; 1986 Jan; 41(1):120-2. PubMed ID: 3510482
    [No Abstract]   [Full Text] [Related]  

  • 44. The peripheral nerve allograft: an assessment of regeneration in the immunosuppressed host.
    Mackinnon SE; Hudson AR; Bain JR; Falk RE; Hunter DA
    Plast Reconstr Surg; 1987 Mar; 79(3):436-46. PubMed ID: 3823218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity and regenerative potential of acellular nerve allografts to repair peripheral nerve in rats and rabbits.
    Gulati AK; Cole GP
    Acta Neurochir (Wien); 1994; 126(2-4):158-64. PubMed ID: 8042549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral nerve allografts stored in green tea polyphenol solution.
    Ikeguchi R; Kakinoki R; Matsumoto T; Hyon SH; Nakamura T
    Transplantation; 2005 Mar; 79(6):688-95. PubMed ID: 15785375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune response and neurotrophic factor interactions in peripheral nerve transplants.
    Gulati AK
    Acta Haematol; 1998; 99(3):171-4. PubMed ID: 9587399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peripheral nerve transplantation: the role of chemical acellularization in eliminating allograft antigenicity.
    Rovak JM; Bishop DK; Boxer LK; Wood SC; Mungara AK; Cederna PS
    J Reconstr Microsurg; 2005 Apr; 21(3):207-13. PubMed ID: 15880301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safe injection of cultured schwann cells into peripheral nerve allografts.
    Ogden MA; Feng FY; Myckatyn TM; Jensen JN; Grand AG; Wood PW; Hunter DA; MacKinnon SE
    Microsurgery; 2000; 20(7):314-23. PubMed ID: 11119286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral nerve allograft: an assessment of regeneration across pretreated nerve allografts.
    Mackinnon SE; Hudson AR; Falk RE; Kline D; Hunter D
    Neurosurgery; 1984 Nov; 15(5):690-3. PubMed ID: 6334246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical applications of peripheral nerve allotransplantation. Present medical experience and review of the literature].
    Jabłecki J; Pielka S
    Neurol Neurochir Pol; 2004; 38(2):137-42. PubMed ID: 15307607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased Cyclosporin A requirement with anti-ICAM-1 and anti-LFA-1 in a peripheral nerve allotransplantation model.
    Fox DJ; Doolabh VB; Mackinnon SE; Genden EM; Hunter DA
    Restor Neurol Neurosci; 1999; 15(4):319-326. PubMed ID: 12671222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral nerve allograft: an immunological assessment of pretreatment methods.
    Mackinnon SE; Hudson AR; Falk RE; Kline D; Hunter D
    Neurosurgery; 1984 Feb; 14(2):167-71. PubMed ID: 6608699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction in peripheral nerve allograft antigenicity with warm and cold temperature preservation.
    Strasberg SR; Mackinnon SE; Hare GM; Narini PP; Hertl C; Hay JB
    Plast Reconstr Surg; 1996 Jan; 97(1):152-60. PubMed ID: 8532773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of research endeavors to optimize peripheral nerve reconstruction.
    Myckatyn TM; Mackinnon SE
    Neurol Res; 2004 Mar; 26(2):124-38. PubMed ID: 15072631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for genetic contamination of inbred buffalo rats (RT-1b) obtained from a commercial vendor.
    Jones RE; Weinberg A; Bourdette D
    J Neuroimmunol; 1994 Jul; 52(2):215-8. PubMed ID: 8034760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of nondepleting anti-CD4 monoclonal antibody (Rib 5/2) plus donor antigen pretreatment in peripheral nerve allotransplantation.
    Doolabh VB; Tung TH; Wayne Flye M; Mackinnon SE
    Microsurgery; 2002; 22(8):329-34. PubMed ID: 12497567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
    Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
    Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.